Make Better Decisions

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Covington
UBS
Harvard Business School
Express Scripts
Novartis
McKesson
Colorcon
Cerilliant
Dow
Fish and Richardson

Generated: January 21, 2018

DrugPatentWatch Database Preview

Tamoxifen citrate - Generic Drug Details

« Back to Dashboard

What are the generic sources for tamoxifen citrate and what is the scope of tamoxifen citrate patent protection?

Tamoxifen citrate
is the generic ingredient in three branded drugs marketed by Midatech Pharma Us, Astrazeneca, Actavis Labs Fl Inc, Aegis Pharms, Apotex, Ivax Sub Teva Pharms, Mayne Pharma, Mylan, Pharmachemie, Roxane, Teva, and Zydus Pharms Usa Inc, and is included in thirteen NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

Tamoxifen citrate has seven patent family members in seven countries.

There are sixteen drug master file entries for tamoxifen citrate. Fourteen suppliers are listed for this compound.
Pharmacology for tamoxifen citrate

US Patents and Regulatory Information for tamoxifen citrate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Roxane TAMOXIFEN CITRATE tamoxifen citrate TABLET;ORAL 076027-001 Feb 20, 2003 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Ivax Sub Teva Pharms TAMOXIFEN CITRATE tamoxifen citrate TABLET;ORAL 075740-001 Feb 20, 2003 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Teva TAMOXIFEN CITRATE tamoxifen citrate TABLET;ORAL 074504-002 Apr 28, 2003 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Aegis Pharms TAMOXIFEN CITRATE tamoxifen citrate TABLET;ORAL 076398-002 Mar 31, 2003 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Midatech Pharma Us SOLTAMOX tamoxifen citrate SOLUTION;ORAL 021807-001 Oct 29, 2005 RX No No ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Mylan TAMOXIFEN CITRATE tamoxifen citrate TABLET;ORAL 074732-001 Feb 20, 2003 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Mayne Pharma TAMOXIFEN CITRATE tamoxifen citrate TABLET;ORAL 075797-001 Feb 20, 2003 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Roxane TAMOXIFEN CITRATE tamoxifen citrate TABLET;ORAL 076027-002 Feb 20, 2003 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Actavis Labs Fl Inc TAMOXIFEN CITRATE tamoxifen citrate TABLET;ORAL 076179-002 Feb 20, 2003 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Actavis Labs Fl Inc TAMOXIFEN CITRATE tamoxifen citrate TABLET;ORAL 070929-001 Feb 20, 2003 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for tamoxifen citrate

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Astrazeneca NOLVADEX tamoxifen citrate TABLET;ORAL 017970-001 Approved Prior to Jan 1, 1982 ➤ Subscribe ➤ Subscribe
Astrazeneca NOLVADEX tamoxifen citrate TABLET;ORAL 017970-002 Mar 21, 1994 ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Teva
Daiichi Sankyo
McKesson
US Department of Justice
McKinsey
UBS
Johnson and Johnson
Argus Health
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot